JohnCO'SheaMD

Cardiology • Durham, NC

Physician

Join to view full profile

Are you Dr. O'Shea?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 28 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1000 Trent Dr
Durham, NC 27710
Phone+1 919-684-8111
Is this information wrong?

Summary

Dr. John O'Shea, MD is a cardiologist in Durham, North Carolina.

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1998 - 2001
Duke University HospitalResidency, Internal Medicine, 1996 - 1998
University College Cork Faculty of MedicineClass of 1989

Publications & Presentations

PubMed

24-hour ambulatory blood pressure monitoring.
O'Shea JC, Califf RM> ;Am. Heart J.. 2006-05-01
Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial).
Reddan, D.N., O'Shea, J.C., Sarembock, I.J., Williams, K.A., Pieper, K.S., Santoian, E., Owen, W.F., Kitt, M.M., Tcheng, J.E.> ;Am J Cardiol. 2003 Jan 1
Statistical issues relating to international differences in clinical trials.
O'Shea JC, DeMets DL> ;Am. Heart J.. 2001-07-01
A tale of two countries: Insights from the differences in Canadian/American patterns of care for patients with acute coronary syndromes.
O'Shea JC, Fu Y, Chang WC, Armstrong PW> ;Am. Heart J.. 2001-07-01
Potential impact of socioeconomic differences on clinical outcomes in international clinical trials.
Shibata MC, Flather MD, de Arenaza DP, Wang D, O'shea JC> ;Am. Heart J.. 2001-06-01
International differences in treatment effects in cardiovascular clinical trials.
O'Shea JC, Califf RM> ;Am. Heart J.. 2001-05-01
International differences in cardiovascular clinical trials.
O'Shea JC, Califf RM> ;Am. Heart J.. 2001-05-01
International differences in cardiovascular clinical trials. Introduction.
O'Shea JC, Califf RM> ;Am. Heart J.. 2001-05-01
Highlights from the XXII congress of the European Society of Cardiology: August 26 to 30, 2000.
McGuire DK, O'shea JC, Dyke CK, Velazquez EJ, Hudson MP> ;Am. Heart J.. 2001-01-01
Inter-regional differences in acute coronary syndrome trials.
O'Shea JC, Calif RM> ;Eur. Heart J.. 2000-09-01
Highlights from the American College of Cardiology 49th Annual Scientific Sessions: March 12 to 15, 2000.
McGuire DK, O'shea JC, Dyke CK, Kandzari DE, East MA, Tolleson TR> ;Am. Heart J.. 2000-07-01
Electronic activity-monitor-derived sleeping and awake times and diurnal variation of blood pressure.
O'Shea, J. C., Murphy, M. B.> ;Blood Press Monit. 2000 Apr
Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001.
Kandzari, D. E., Kay, J., O'Shea, J. C., Trichon, B. H., Donahue, M., Liao, L., Rao, S. V.> ;Am Heart J. 2002 Feb
Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis.
Mehta, R. H., O'Shea, J. C., Stebbins, A. L., Granger, C. B., Armstrong, P. W., White, H. D., Topol, E. J., Califf, R. M., Ohman, E. M.> ;J Am Coll Cardiol. 2011 Jan 11
Part I: Identifying holes in the safety net.
O'Shea, J. C., Kramer, J. M., Califf, R. M., Peterson, E. D.> ;Am Heart J. 2004 Jun
Effects of 308 nanometer excimer laser energy on 316 L stainless-steel stents: implications for laser atherectomy of in-stent restenosis.
Burris, N., Lippincott, R. A., Elfe, A., Tcheng, J. E., O'Shea, J. C., Reiser, C.> ;J Invasive Cardiol. 2000 Nov
ESPRIT in context: pharmacology matters!
Tcheng, J. E., Strony, J., Lorenz, T. J., O'Shea, J. C.> ;Eur Heart J. 2001 Nov
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone.
O'Shea, J. C., Wilcox, R. G., Skene, A. M., Stebbins, A. L., Granger, C. B., Armstrong, P. W., Bode, C., Ardissino, D., Emanuelsson, H., Aylward, P. E., White, H. D., ...> ;Am J Cardiol. 2002 Dec 15
Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa.
O'Shea, J. C., Tcheng, J. E.> ;Expert Opin Pharmacother. 2002 Aug
A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting.
Madan, M., Labinaz, M., Cohen, E. A., Buller, C. E., Cantor, W. J., Seidelin, P., Ducas, J., Carere, R. G., Natarajan, M. K., Pieper, K. S., Hafley, G. E., O'Shea, J. ...> ;Can J Cardiol. 2004 Nov
Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.
Tcheng, J. E., Madan, M., O'Shea, J. C., Cohen, E. A., Buller, C. E., Lincoff, A. M., Popma, J. J., Teirstein, P. S., Kitt, M. M., Lorenz, T. J., Greenberg, S., Fost, ...> ;J Interv Cardiol. 2003 Apr
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention.
Gilchrist, I. C., O'Shea, J. C., Kosoglou, T., Jennings, L. K., Lorenz, T. J., Kitt, M. M., Kleiman, N. S., Talley, D., Aguirre, F., Davidson, C., Runyon, J., Tcheng, ...> ;Circulation. 2001 Jul 24
Eptifibatide in percutaneous coronary intervention. A review.
Dery, J. P., O'Shea, J. C., Tcheng, J. E.> ;Minerva Cardioangiol. 2002 Oct
Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study.
Fernandes, L. S., Tcheng, J. E., O'Shea, J. C., Weiner, B., Lorenz, T. J., Pacchiana, C., Berdan, L. G., Maresh, K. J., Joseph, D., Madan, M., Mann, T., Kilaru, R., Ho...> ;J Am Coll Cardiol. 2002 Sep 18
Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.
Blankenship, J. C., Tasissa, G., O'Shea, J. C., Iliadis, E. A., Bachour, F. A., Cohen, D. J., Lui, H. K., Mann, T., Cohen, E., Tcheng, J. E.> ;J Am Coll Cardiol. 2001 Sep
Join now to see all